top of page
Untitled.jpg

Spravato® Treatment

An FDA-approved treatment option at Ascend Mental Health Center for adults with treatment-resistant depression.

DSCF6625.jpg

A Regulated, Evidence-Based Treatment for Persistent Symptoms

Spravato® (esketamine) is an FDA-approved medication for adults diagnosed with treatment-resistant depression. It is administered only in certified medical clinics under the strict REMS (Risk Evaluation and Mitigation Strategy) program.

At Ascend Mental Health Center, Spravato® is delivered with careful monitoring, clear communication, and a structured plan designed around safety and clinical effectiveness.

DSCF6631 (1).jpg

Frequently Asked Questions

Find answers to common questions about our medication management.

  • Ketamine treatment is safe when provided in a clinical setting. At Ascend Mental Health Center, we prioritize your safety. Before treatment begins, you will undergo an evaluation of your health history and current status to ensure you are a qualified candidate. Every session is medically supervised by trained professionals who continuously monitor your vital signs and comfort levels. We are committed to providing a calm, controlled environment to facilitate a positive and therapeutic experience.

Need more information?

Reach out to our team for any specific questions you may have!

Untitled_edited.jpg

Our goal is simple:

To help you find relief in a setting that feels supportive, predictable, and grounded in medical best practices.

Screenshot 2026-05-12 at 3.47.03 PM (1).png

What Spravato® May Help With

Spravato® may be appropriate for individuals who are:

Living with treatment-resistant depression

Taking an oral antidepressant without adequate improvement

Experiencing symptoms that significantly impact daily functioning

Evaluated by a provider and determined to be a good candidate for the REMS program

How Spravato® Treatment Works at Ascend

Step 1

Comprehensive Evaluation

Your provider conducts a thorough assessment, reviews your medication history, and determines whether Spravato® meets FDA criteria for treatment-resistant depression.

Step 2

Personalized Treatment Planning

If Spravato® is appropriate, your provider outlines a structured dosing schedule and explains what to expect during the REMS-required monitoring period.

Step 3

In-Clinic Administration Only

Spravato® is administered as a nasal spray in our Idaho Falls clinic. Patients self-administer the medication under direct supervision, and the remainder of the session is monitored by clinical staff.

Step 4

Continuous Medical Monitoring

For the required two-hour monitoring period, our team checks vital signs, clinical response, and overall safety. You remain in a private, comfortable space for the full observation period.

Step 5

Recovery and Post-Session Review

Before leaving, a provider confirms medical stability and reviews next steps. You may not drive until the following day; transportation must be arranged ahead of time.

Step 6

Ongoing Evaluation and Adjustment

Treatment progress is reviewed at each visit. Your provider may adjust dose levels, frequency, or your overall treatment plan to ensure the safest and most effective outcome.

Untitled.jpg

More Resources

Spravato Brochure
Download PDF
Patient Identification Guide
Download PDF
Spravato's Website
View Website
DSCF6635.jpg

Clinical Spravato® Treatment You Can Trust

Spravato® treatment at Ascend is administered only in a certified clinical setting and follows all REMS program requirements. Our team provides structured monitoring to ensure each session is safe, consistent, and medically supervised from start to finish.

Spravato® treatment at Ascend includes:

Controlled in-clinic administration under REMS guidelines

Mandatory medical observation for the full monitoring period

Structured dosing and monitoring protocols

Coordination with your ongoing medication management

Clear pre-appointment and post-appointment guidance

Your safety, stability, and clarity are always the primary focus

Ketamine vs. Spravato®

Ascend offers both IM ketamine and Spravato® (esketamine). Your provider will explain the differences and help you understand which option best aligns with your symptoms and medical history.

Frame 15

Ketamine (IM)

Generic Medication

Used off-label for depression under medical supervision

Delivered by intramuscular injection

Ketamine
Frame 16

Spravato®

FDA-approved esketamine nasal spray

Approved specifically for treatment-resistant depression

Requires two hours of monitoring per REMS guidelines

Spravato
Untitled.jpg

Is Spravato® Right for You?

Rapid and Efficient Absorption

Convenient, IM Treatment Experience

Professional Supervision and Swift Recovery

If you’re considering Spravato® as part of your treatment plan, submit a New Patient Request. We will contact you to schedule an evaluation and outline the next steps.

Contact Us

As responses may take up to one business day, if you feel you need immediate care or are in crisis, call 988 or go to the nearest emergency room. This form is not designated for urgent patient communications.

Untitled_edited.jpg
Untitled_edited.jpg

Start Your Care With Us

Submit a New Patient Request, and our team will follow up to schedule your evaluation.

bottom of page